FDA grants expanded approval for Bristol Myers Squibb anemia therapy - NJBIZ
Por um escritor misterioso
Last updated 26 abril 2025

“The approval of Reblozyl in the first-line treatment of anemia for patients with lower-risk MDS represents a crucial step in making transfusion independence possible for more patients," said Tracey Iraca, executive director of the MDS Foundation.

Bristol Myers Squibb - Recent News & Activity

Making a list - NJBIZ

TechLaunch names winners at virtual pitch event - NJBIZ

FDA Approves Bristol Myers Squibb Anemia Treatment

Bryan Bloom, Author at NJBIZ

Bristol-Myers Squibb Baraclude Patient Assistance - Needy Meds

Playing catch-up - NJBIZ
/cloudfront-us-east-2.images.arcpublishing.com/reuters/GFWI6STKHJMH3I3AD6W3HZVHD4.jpg)
US FDA approves Bristol-Myers' lung cancer drug
List of top City of New York Venture Stage Investors - Crunchbase Hub Profile